About David Beno
Form D filings for Xeno Biosciences from 2018 to 2023 list David Beno as chief executive officer and director.
David Beno first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name David Beno in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people David Beno works with at each company, as listed on that company's latest Form D.
Xeno Biosciences Inc. · Form D, Jan 5, 2023